1. 1098. A Phase 1 Safety and Tolerability of Single Ascending Doses of a Novel Engineered Cationic Peptide, PLG0206, in Healthy Subjects. (4th December 2021) Authors: Huang, David; Dobbins, Despina; Ghahramani, Parviz; Steckbeck, Jonathan Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S641 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1098. A Phase 1 Safety and Tolerability of Single Ascending Doses of a Novel Engineered Cationic Peptide, PLG0206, in Healthy Subjects. (4th December 2021) Authors: Huang, David; Dobbins, Despina; Ghahramani, Parviz; Steckbeck, Jonathan Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S641 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1324. Target Attainment of Exebacase, a First-In-Class Antibacterial Lysin, to Determine Optimal Doses for Adult Patients with Staphylococcus aureus (S. aureus) Bloodstream Infections (Bacteremia) Including Endocarditis. (31st December 2020) Authors: Ghahramani, Parviz; Khariton, Tatiana; Chiu, Joannellyn; Cassino, Cara Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S673 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Coronary and cardiovascular risk estimation for primary prevention:validation of a new Sheffield table in the 1995 Scottish health survey population. Issue 7236 (11th March 2000) Authors: Wallis, Erica J; Ramsay, Lawrence E; Haq, Iftikhar UI; Ghahramani, Parviz; Jackson, Peter R; Yeo, Karen Rowland; Yeo, Wilfred W Journal: BMJ Issue: Volume 320:Issue 7236(2000) Page Start: 671 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Modeling and simulation the conduit connecting translational medicine with portfolio management. Issue 2 (January 2015) Authors: Ghahramani, Parviz Journal: New horizons in translational medicine Issue: Volume 2:Issue 2(2015) Page Start: 63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Relationship Between Plasma Concentrations and Clinical Effects of Cariprazine in Patients With Schizophrenia or Bipolar Mania. Issue 2 (27th December 2019) Authors: Periclou, Antonia; Willavize, Susan; Jaworowicz, David; Passarell, Julie; Carrothers, Timothy; Ghahramani, Parviz; Durgam, Suresh; Earley, Willie; Kapás, Margit; Khariton, Tatiana Journal: Clinical and translational science Issue: Volume 13:Issue 2(2020) Page Start: 362 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Safety and Pharmacokinetics of Exebacase in an Infant With Disseminated Staphylococcus aureus Infection . (11th December 2021) Authors: Moorthy, Ganga S; Greenberg, Rachel G; Hornik, Chi D; Cassino, Cara; Ghahramani, Parviz; Kumar, Karan R; Fowler, Vance G; Cohen-Wolkowiez, Michael Journal: Clinical infectious diseases Issue: Volume 75:Number 2(2022) Page Start: 338 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Translational Medicine definition by the European Society for Translational Medicine. Issue 3 (March 2015) Authors: Cohrs, Randall J.; Martin, Tyler; Ghahramani, Parviz; Bidaut, Luc; Higgins, Paul J.; Shahzad, Aamir Journal: New horizons in translational medicine Issue: Volume 2:Issue 3(2015) Page Start: 86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗